Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Forecast: in 1 year, the Aviva share price could turn £1,000 into…
    News

    Forecast: in 1 year, the Aviva share price could turn £1,000 into…

    userBy userJune 9, 2025No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Despite suffering some double-digit volatility in April, the Aviva (LSE:AV.) share price has bounced back nicely. And anyone who used the market turmoil as an opportunity to top up their position or open a new one is already sitting on a 24% return.

    Some of this momentum’s undoubtedly driven by a general rise in investor and consumer sentiment following the US tariff announcements. However, shareholders have also received the group’s first-quarter trading results for 2025. And they didn’t disappoint:

    • General insurance premiums up 9% to £2.9bn.
    • Retirement sales up 4% to £1.8bn.
    • Protection & Health sales up 19% to £126m.

    For a £16.5bn market-cap insurance giant, those figures are pretty strong – a conclusion that analysts at Jefferies also reached. And if everything goes according to plan with its Direct Line Insurance takeover, management expects the subsequent synergies to bolster profitability as well as accelerate its transition into a capital-light business model.

    With that in mind, it’s not surprising to see institutional analysts like Jefferies issue Buy ratings on the stock. But how much money could an investor make if they bought £1,000 worth of shares today?

    Zooming in on the valuation

    A big part of Aviva’s appeal is the firm’s 2026 goals. The company’s targeting an operating profit of £2bn and a Solvency II Operating Free Capital Generation of £1.8bn (similar to free cash flow for insurance companies).

    Both figures will help sustain and grow shareholder dividends as well as the business itself. And looking again at the first quarter results, Aviva seems to be on track to hit both of these milestones. This is likely why most institutional investors are currently bullish on the stock in terms of their Buy and Outperform recommendations.

    However, when looking at the share price forecasts, Aviva doesn’t seem to be as tempting. Even Jefferies, who recently praised Aviva’s progress, still only has a 560p share price target. And while other analysts are a bit more optimistic, most of the forecasts for the Aviva share price sit between 600p and 620p – right around where the stock trades today.

    In other words, the company’s expected future returns are already seemingly baked into its stock price. Therefore, unless management’s able to surprise investors with even better than expected results, investing £1,000 today could be worth around the same amount by this time next year.

    Risk versus reward

    The 5.8% dividend might look enticing for income investors seeking a stable base. However, with growth expectations baked in, any hiccup over the next 12 months could trigger a tumble.

    Right now, one of the biggest speedbumps the company needs to overcome is getting the regulatory green light from the Competition and Markets Authority (CMA). The CMA has flagged the Direct Line Insurance Group deal as potentially problematic, launching an official review with a deadline of 10 July.

    The announcement didn’t cause a major shift in the Aviva share price, suggesting that most investors believe the deal will receive approval. However, should the CMA decide to block the transaction, growth expectations could be in for a sharp correction.

    This regulatory uncertainty, paired with a fully realised valuation, makes Aviva a rather untempting investment right now, at least for my portfolio. But should a more attractive entry point emerge, I may have to reconsider.



    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleTrump-induced turbulence hits Hong Kong dollar, interest rates
    Next Article Looking to de-risk a Stocks and Shares ISA? Consider this!
    user
    • Website

    Related Posts

    If an investor bought on the Lloyds share price pandemic crash, here’s what the stake would be worth now

    June 9, 2025

    2 excellent growth stocks to consider buying for an ISA in June

    June 9, 2025

    With a 6% yield and a decade of growth, is this FTSE 100 dividend stock a no-brainer buy?

    June 9, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d